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ABSTRACT
Autism spectrum disorder has been dramatically on the rise since the early
1990s, with one in forty-five children being diagnosed in 2014. It is known that
contributing factors to autism spectrum disorder may have genetic and epigenetic origins,
as well as environmental triggers. What is still unclear, however, is the impact of
teratogenic drugs, consumed by the mother, have on a developing fetus in utero. How
can they lead to the child developing autistic-like behaviors? The current study
documents the effects of one teratogenic drug Valproic acid, a known histone deacetylase
inhibitor. It establishes the role it plays on developing neurites and synapses within the
brain. This study supports Markram's proposal of an "intense world theory"
characterized by autistic-like behaviors due to hyper-functioning microcircuits within the
brain. Dorsal root ganglia were dissected out of eight day old chick embryos, some of
which were exposed to varying concentrations of Valproic Acid, to serve as a model for
this study. The dorsal root ganglia were cultured for 48 hours and then underwent a three
day immunostaining procedure in order for their neurites and synapses to be observed
clearly under the microscope. Composite images of each dorsal root ganglia were
constructed using the tiling program ImagePro Premier. This program was also then
used to count neurites and measure their lengths. Another program ImageJ was used to
measure the area of synaptogenesis. Dorsal root ganglia exposed to Valproic Acid
developed more and longer neurites when compared to controls. When exposed to a
specific concentration they began to develop larger synaptogenic areas. These findings
support Markram's "intense world theory" in demonstrating that in utero exposure to

Valproic Acid may cause hyper-functioning synapses; begging to question as to whether
or not other histone deacetylase inhibitors have the same effect.
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CHAPTER 1
INTRODUCTION
Since the early 1990s there has been an evident increase in the number of
children affected with autism spectrum disorder (ASD). There are many factors that may
contribute to this increase including, but not limited to, genetic, epigenetic, and
environmental conditions. Greater awareness and better diagnosis may explain some, but
cannot explain the nearly exponential increase. This study investigates the epigenetic
effects by examining the teratogenic drug valproic acid and its impact on embryonic
neurons in culture. This approach should provide insight into one factor contributing to
the etiology of autism at the cellular level.

Literature Review
Autism Spectrum Disorder
ASD can be defined as a complex developmental disability with symptoms
typically appearing in early childhood that affects a person’s ability to communicate and
interact with others (Autism Society 2016). ASD has increased in prevalence among
children, with cases jumping from one in two hundred-fifty reported in 2001 to one in
forty-five in 2014 (Autism Speaks 2015). This data leads to the question as to what is
causing this dramatic increase in the number of children reported with ASD. Certainly as
technology and awareness of ASD advance, medical professionals are more apt to know
the early signs and symptoms of ASD and are able to make improved diagnoses. Yet it is
improbable that this accounts for all of the increase. Signs and symptoms of autism can
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be divided into five categories: behavioral, developmental, cognitive, psychological, and
other. 1) Behavioral signs include inappropriate social interaction, poor eye contact,
compulsive behavior, impulsivity, repetitive movements, self-harm, and persistent
repetition of words or actions. 2) Learning disabilities or speech delay are examples of
developmental symptoms. 3) Intense interest in a limited number of things or problems
paying attention fall under cognitive symptoms. 4) Psychological signs include
unawareness of others' emotions or depression. 5) Other signs include but are not limited
to anxiety, change in voice, excessive sensitivity to sound, or a tic (summarized from the
CDC 2015). There is no known single cause for autism, but evidence supports
involvement of genetic and epigenetic factors. This paper will focus on epigenetic
factors that may lead to hypo- and hyper-connectivity of neurons in the developing brain.
Valproic Acid
Valproic Acid (2-n-propyl pentanoic acid, VPA) is a medication primarily used
to treat epilepsy and seizures, but also as an antipsychotic for bipolar disorder, and
migraine treatment. It may also be used to treat children with attention-deficit/hyperreactivity disorder (ADHD). VPA has known teratogenic effects and has been linked to
malformations in humans and other animals when exposed in utero, a configuration of
symptoms known as fetal valproate syndrome (FVS) in humans (DiLiberti et al. 1984).
FVS is reported as showing congenital malformations, dysmorphism and abnormal
neurological signs at birth (Laegreid et al. 1993). Larger studies have provided evidence
that VPA exposure and the development of FVS in utero may be linked to an increased
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risk of ASD, reporting the rate of ASD to be eight times larger in VPA treated mothers
than the general population (Rasalam et al. 2005).
The “Intense World Theory”
The “intense world theory” of ASD can be described as excessive neuronal
information processing and storage in the microcircuits of the brain that can produce
hyper-perception, attention, and memory in those affected. The cause of excessive
processing may be attributed to hyper reactivity and plasticity of the microcircuits
including hyper-connecting neighboring neurons producing excessive excitation as well
as hyper-expressing N-methyl-D-aspartate (NMDA) receptors producing excessive
plasticity in the neocortex. The microcircuits may then become increasingly difficult to
control and coordinate with other microcircuits when activated (summarized from
Markram et al. 2007). The hyper-functioning of microcircuits is expressed physically as
it produces outward signs including decreased social interactions, excess sensitivity to
pain, increased sensitivity to non-painful stimuli, repetitive activity, increased anxiety
and high and longer fear memories that are harder to extinguish (Ebert and Greenberg
2013). These outward signs correlate with many of the symptoms of ASD.
Rodent Model
Rodent models of ASD have frequently been used in research in order to exhibit
the behavioral and neurological effects of prenatal VPA exposure. In a study performed
by Schneider and Przewlocki (2004) rats were exposed to VPA on the 12.5 day of
gestation with offspring’s social behavior being examined in adulthood. Their findings
included a lower sensitivity to pain with higher sensitivity to non-painful stimuli,
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diminished acoustic pre-pulsed inhibition, repetitive and lower exploratory activity, and a
decreased number of social behaviors (Schneider and Prezwlocki 2004). These behaviors
can all be placed into one of the five categories listed above as typical signs and
symptoms of ASD in children.
Another study (Go et al. 2012) examined neuronal developmental effects of
prenatal VPA exposure in rats. One of their findings was induced macrocephaly with
prenatal exposure to VPA. This corroborates previous studies that found enlarged brain
circumference in patients exhibiting ASD and FVS (Yoo et al. 2002). Go and colleagues
also reported an increase in the proliferation of neural progenitor cells (NPC) resulting in
a delayed, but eventual increase in the number of differentiated neurons. Affected
cortical areas showed increased thickness, signifying that numbers of excitatory neurons
may also be increased along with total number of neurons. Increasing excitatory neurons
with or without affecting (but leading to a down-regulation) inhibitory neurons would be
enough to induce abnormal behavior such as repetitive and restricted behaviors, and also
low pre-pulse inhibition, as mentioned above from the previous study of Schneider and
Przewlocki (2004) (summarized from Go et al. 2012).
Investigating further effects on neurons, Mi Ra Jeong and colleagues (2003)
reported a study in which they harvested and cultured cortical neurons (CCN) from 17
day old embryonic rats and treated them with 0.1-1 mM VPA starting at day 9 in vitro.
CCNs not treated with VPA underwent spontaneous cell death with increasing age.
However, VPA treated CCN’s spontaneous cell death was noticeably suppressed,
suggesting a neuroprotective effect of VPA. This was accompanied by a more than two-
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fold increase of histone H3 acetylation, suggesting an inhibition of histone deacetylases
(Jeong et al. 2003).
Mechanism of Action
There is no single mechanism of action for VPA as it dissociates into valproate
ions leading to multiple effects on neuronal tissue in the brain. VPA increases brain
concentrations of GABA (gamma-aminobutyric), an inhibitory neurotransmitter, which
prevents seizures. However, VPA is also thought to enhance the effects of pre-existing
GABA on its receptors and on NMDA glutamate receptors, also contributing to its
anticonvulsant effect (summarized from Smith 2015).
Histone Deacetylase Inhibition
VPA is a known histone deacetylase (HDAC) inhibitor. Histone deacetylases
are important in regulating gene transcription and phenotype expression by functioning as
transcriptional repressors. HDACs have also been shown to act on many cellular
substrates as well as on histones, demonstrating that acetylation may rival
phosphorylation in importance (reviewed by Haberland et al. 2009). HDACs can be
separated into two classes: HDACI and HDACII. MacDonald and Roskam (2008)
observed that HDACI is expressed in neural stem cells/progenitors, but as they exit the
cell cycle HDACI expression is lost. Expression of HDACI is however maintained in glia
throughout the cell cycle. HDACII is initiated in postmitotic neuroblasts and neurons,
and upregulated as they commit to a neuronal lineage, but is not expressed in fully
differentiated glia. Studies have suggested that HDACI may contribute to fate decisions
and lineage commitment and be a prominent player in deacetylation during glial
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development. On the other hand, HDACII may contribute to the regulation of subsets of
neuronal genes during the differentiation of neurons (MacDonald and Roskam 2008). A
study done by Akhtar and colleagues (2009) used electrophysiological,
immunocytochemical, and optical methods to demonstrate that HDACI- and HDACIImediated chromatin silencing restricts the progression of excitatory synapse maturation
during early synapse development. They suggest that the chromatin state maintained by
HDACs suppresses excitatory neurotransmission when synapse formation is sparse, but
augments excitation when neuronal networks mature and synapses are in abundance
(Akhtar et al. 2009). Immature neural networks may have an enhanced vulnerability to
HDAC inhibition leading to prominent increases in the structural assembly of synapses
and growth of neural networks (Chomiak et al. 2013).
VPA accomplishes HDACI inhibition by binding to its catalytic site and
blocking substrate access. However it inhibits HDACII by inducing proteasomal
degradation (Chomiak et al. 2013). Phiel and colleagues (2001) also reported that VPA
acts as a HDAC inhibitor. They proposed that HDAC inhibition by VPA activates Wntdependent gene expression that leads to increased expression of β-catenin and derepression of Tcf/Lef (group of transcription factors involved in the Wnt signaling
pathway). This can lead to the over-connectivity and hyper-excitability described in the
intense world theory (Phiel et al. 2001).
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Histone Methylation
As is the case with histone deacetylation, histone methylation is an important
epigenetic function for regulating gene transcription, developmental gene programs, and
cellular phenotype (Chomiak et al. 2013). Histone lysine methylation occurs on histones
H3 and H4 and they can be mono-, di-, or tri-methylated. Depending on the site of
methylation it can signal either activation or repression. It is speculated that methyl-H3K4 and methyl-H3-K9 are binding sites for proteins that mediate the biological effects of
histone methylation modifications (Martin and Zhang 2005). It is accepted that the trimethylation of histone H3-K4 is very important for transcriptional activation at promotor
regions (Mosammaparast and Shi 2010), whereas methylation of H3-K9 may act to
silence genes (Berger 2007).
In order to examine the effects of VPA on histone methylation and subsequent
gene expression, Tung and Winn (2010) exposed pregnant mice to 400mg/kg VPA and
collected their embryos at successive stages after injection with VPA. They then
examined the effects on histone methylation. They observed a significant decrease in the
expression of monomethyl histone H3-K9 and a significant increase in the expression of
di- and tri-methylated histones H3-K4 suggesting a shift towards more active gene
expression in the embryos (summarized from Tung and Winn 2010).
Rinaldi and colleagues (2007) exposed rat pups prenatally to VPA in order to
investigate alterations made to the glutamatergic system and its second messenger
pathways. They found an overexpression of NMDA receptor subunits leading to
enhanced NMDA receptor-mediated synaptic currents and amplified postsynaptic
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plasticity in neocortical pyramidal neurons (Rinaldi et al. 2007). NMDA receptors
regulate the expression of brain-derived neurotrophic factor (BDNF). An overexpression
of NMDA receptors leads to an overexpression of BDNF, which in turn increases
dendritic growth in neurons (Horch and Katz 2002).
Dorsal Root Ganglia
Vertebrate embryos form a transient ectodermal structure known as the neural
crest from which a subpopulation of migratory neural crest cells (NCCs) emerges. An
epithelial to mesenchyme transition (EMT) facilitates the migration of NCCs from the
dorsal neural tube outward through the extracellular matrix towards remote target
destinations where they differentiate into a wide array of diverse tissues.
In one such differentiation, NCCs develop into the dorsal root ganglia (DRG).
The NCCs that form DRGs migrate a short distance through anterior somite tissue and
then settle segmentally in clusters to differentiate as bipolar neurons and glia. As they
continue to develop, DRGs send neural processes outwards to form junctions at target
tissues and also inward medially to the spinal cord. The DRGs contain the greatest
proportion of sensory neurons that transmit information from the periphery into the
central nervous system (Krames 2014) which can be explanted to tissue culture to create
an experimental model of neural outgrowth (Cohen et al. 1954; Levi-Montalcini 1964;
Letourneau 1975). Once adhered in their target tissue a neural network forms and
neurites begin to extend outward to form synaptic networks which can be detected by
immunostaining with an SV2 antibody (Wiens et al. 2016). A neurite is defined as any
projection from the body of a nerve cell (neuron), either an axon or a dendrite (Collins
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English Dictionary). Growing axons then navigate through the cellular terrain and
associated extracellular matrix to find appropriate synaptic partners. They accomplish
this through the use of growth cones, a specialized structure at the tip of growing axons,
first discovered by Harrison (1910). The morphology of a growth cone is a sheetexpansion of the growing axon at its tip called a lamellapodium with many fine processes
called filopodia that extend and retract to sense the environment and afford transient
adhesion sites. Growth cones explore the extracellular environment in order to determine
the direction of growth and guide the axon’s extension in that direction (Purves et al.
2001). There are three important families of molecules that guide growth cones to their
target destinations. The first, cell adhesion molecules, reside on cellular surfaces and
extracellular matrix substrates along the path the growth cone is traveling and are
recognized by specific receptors on the growth cone’s membrane. Once contact has been
made, other signals are transmitted to the cytoplasm and set the direction for growth cone
adhesion and motility. The second family contributing to growth cone guidance are
diffusible molecules that guide the growth cone through chemotaxis by diffusing freely
into the aqueous environment surrounding the growth cone. They may either attract or
repel the growth cones. The third family consists of growth (trophic) factors that are also
small diffusible molecules but act more generally to stimulate elongation of the axon and
the formation of synaptic connections (McGill 2013).
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Hypothesis
Because VPA is known to mimic ASD in rodents by altering brain development
via epigenetic dysregulation (Chomiak et al. 2013), it is important to examine its effects
directly on the developmental cellular behavior of neurons. One suitable experimental
system that can be used to examine this is DRG neurons in culture (Wiens et al. 2016).
Therefore I have used immunostaining procedures and microscopic image analysis to
investigate the neurites, growth cones, and neural networks of DRGs in eight-day-old
chick embryos treated with increasing concentrations of VPA. I have compared them to
untreated controls. As previous studies suggest, VPA should stimulate some or all
neurogenic activities. Therefore, I expect to find an increase in neurite number and
length with an increase in area of synaptogenesis in treated DRGs compared to controls.
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CHAPTER 2
MATERIALS AND METHODS
Dissection and Culture
Fertile chicken eggs were purchased from Mixdorf farms (Waterloo, IA) and
incubated at 38˚C for eight days. The method for dissection and culture of the DRGs by
Wiens et al (2016) was followed. On the eighth day embryos were extracted from the
eggs and transferred to a petri dish containing Earle's Balanced Salt Solution (EBSS)
(Sigma-Aldrich). Each embryo was then placed into a sterile dish under a binocular
microscope for dissection. The head and internal organs were removed in order to
expose the spinal cord. Then, microscissors (Minitool, Inc., Los Gatos, CA) were used to
sever the dorsal roots and excise the small, ovoid DRGs from their location near the
spinal cord. A micropipette was used to transfer them out of the dish into a second sterile
dish of EBSS. Twenty-five to thirty DRGs were typically collected from each embryo
and the dish was then carefully transferred to a laminar flow hood to prepare the DRGs
for culture. Five to six DRGs were transferred via micropipette from the EBSS into
Falcon Primaria 35 mm diameter culture dishes (Fisher Scientific) to ensure that two or
more would attach. Excess EBSS was removed and 2 mL of Medium 199 (SigmaAldrich), supplemented with 10% fetal bovine serum (MP Biomedicals, Santa Ana, CA)
and 1% antibiotic/antimycotic solution (CellnTec, Bern, Switzerland) was added to each
dish. Either 1, 2, 4, or 6 µL of VPA (2-propylpentanoic acid, Sigma-Aldrich) was added
to the experimental dishes from a 2.0 M stock solution to achieve final concentrations of
50, 100, 200, or 300 µM. Control dishes received equivalent volumes of medium only.
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The dishes were then incubated at 38 °C with 5% CO 2 and 100% humidity for 36-48
hours. Attachment was observed by 24 hours for all conditions, and those explants not
attached were excluded from the experiment.
Fixation and Immunostaining
Following culture the DRGs were taken out of incubator and the dishes were
immediately placed on ice in order to stop neural outgrowth and development. The
medium was then pipetted out and replaced with EBSS briefly to wash, and then 1 mL of
ice cold 20% DMSO in methanol was pipetted into the dishes on ice for one hour with
gentle agitation in order to fix the DRGs. The method for the immunostaining of fixed
DRGs was the method of Wiens et al (2016). Briefly, after one hour of fixation, the
cultures were washed with a phosphate buffer saline (PBS) solution three times for two
minutes each. A peroxidase quenching solution (3% H 2 O 2 in methanol) was added to the
dishes for ten minutes followed by 3 PBS washes. The cultures were then permeabilized
with gentle agitation for thirty minutes in 0.1% Triton X-100 in PBS followed by 3 more
PBS washes. Blocking solution (0.5% Tween-20, 2.5% bovine serum albumen, 0.5%
nonfat dry milk in PBS) was then added for one hour with gentle agitation. Mouse
monoclonal antibody SV2 (Developmental Studies of Hybridoma Bank, University of
Iowa Department of Biological Sciences, Iowa City, IA) secreted into culture solution
was added to the blocking solution in a 1:20 dilution and incubated at 4°C overnight.
The next day the cultures were warmed to ambient temperature with gentle agitation.
The antibody-blocking solution mixture was removed and they were washed three times
in PBS. Biotinylated anti-mouse IgG from a Histostain SP kit (Invitrogen) was added to
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the dishes for 20 minutes followed by PBS washing three times and then streptavidinperoxidase conjugate solution, also from the kit, was added for 15 minutes with gentle
agitation followed by PBS washing 3 times. A chromagen mixture containing 1% 3amino-9-ethylcarbazole and 0.3% H 2 O 2 in 0.05M acetate buffer was placed on the
cultures and allowed to develop in darkness for 10 minutes after which antibody-positive
DRGs were stained red. This was then removed and the cultures immediately rinsed with
dH 2 O to stop the reaction. The stained cultures were then post-fixed in 3.7%
paraformaldehyde solution at 4 °C for eight minutes to stabilize the red color. The
cultures were then rinsed and stored in the refrigerator in dH 2 O.
Seven control DRGs were also immunostained in the same way but without
addition of the primary antibody. Without adding primary antibody, the chromagen
mixture could not adhere to synaptic vesicles and thus not stain red. This showed that the
immunostaining procedure was successful and that no non-specific binding occurred.
Image Analysis in Image Pro Premier
Image composites and neurite and growth cone measurements were made using
Image Pro Premier software (Media Cybernetics, Inc., Rockville, MD). The culture dish
was placed on the stage of a Leica DMIRE-2 inverted microscope with Q-Imaging CCD
camera (Surrey, BC, Canada) attached and the DRG of interest was located and adjusted
into focus using differential interference contrast optics on the screen of a Dell Optiplex
980 computer. Commands in the Image Pro Premier program were then used to tile the
DRG with the 10x objective of the microscope in position until a composite image was
created. This was then saved as a .tiff image. Image tiling refers to capturing multiple
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images at an increased magnification and then aligning and joining them in order to
create one composite image. After the DRG images had been tiled and saved they were
opened again in Image Pro Premier to count and measure neurites. Before beginning the
measurements the program was calibrated from pixels to micrometers using a section of
ruler that had been tiled as before and setting the scale in the software. A tiled image was
then opened and twelve radial lines were drawn at successive 30° angles from the center
of each explant (Figure 1). Any neurite touching or crossing a line was counted and
measured for length by using the mouse to trace it from where it began at its
corresponding cell body or dendrite to where it ended at either another cell body or in the
field of view. This ensured a selection of a random representative sample. The numbers
given for length were then divided by two because the Image Pro program was increasing
the number of pixels during tiling by overlapping the joined images. This number was
determined by comparing an uncalibrated tiled image to an image that was calibrated
before and during tiling to compare pixels per unit. Multiple explants were tested this
way to give an average ratio of 0.5, thus dividing all initial measurements in half. The
measurements were then saved in a Microsoft Excel file for further analysis.
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Figure 1. Composite image of a DRG showing a dense neuronal network. Random
assessment was achieved by only counting and measuring neurites that touched or
crossed any one of the twelve lines shown drawn at 30° angles from the center of the
explant. (All markings shown as “PL” indicate neurites traced).

Image Analysis in ImageJ
The red stained area of synaptogenesis was measured using the color
thresholding feature in the program ImageJ. First, the program was used to cut out the
central DRG original explant (Figure 2). This was necessary because of its 3dimensional complexity that made color thresholding inaccurate. Furthermore, the aim
was to assess synapse formation among neural connections that had been created during
the period of culture, and these were peripheral. There was a definite visible depth
change among cells at the explants’ edge which was used to determine the border of the
explant to cut out. The color thresholding option of ImageJ was then used to find the
total area of all the pixels above a computer-determined level of red intensity. The total
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area was then divided by two to account for the overlapped images created during tiling.
It was also necessary to account for the variation in size of the explants. A larger explant
will have a larger synaptic area by default. This was done by measuring the largest
diameter of the cleared portion of each explant, finding the average of these, and dividing
the average by each diameter. This gave a diameter quotient that we used to adjust each
peripheral area measured. The corrected areas were lastly divided by their respective
diameter quotient to end with our area of synaptogenesis in square microns used for
analysis.

Figure 2. Composite images of cultured DRGs in ImageJ program. A) Control DRG with
the central DRG cut out to measure synaptogenic area around peripheral edges. B) DRG
exposed to 100µM concentration of VPA with the central DRG cut out to measure
synaptogenic area around peripheral edges.
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Statistical Analysis
The raw measurements for the neurites were initially saved in Excel files and
then sorted and saved as CSV files for further analysis. R language for statistical
computing (R Core Team, 2012) was used to create histograms and boxplots of the data.
Significance values for neurite length and synaptogenic area were p ≤ 0.05 and were
computed in R using the Wilcoxon Rank Sum Test because the histogram data analysis
showed the values were not normally distributed. Histogram data for neurite number
showed normally distributed values, so significance was computed using a T-TEST in
Microsoft Excel. The histograms can be seen in Appendix A.
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CHAPTER 3
RESULTS
In this study, I carried out experiments in order to observe if there was evidence
that the pharmaceutical valproic acid may cause increased neuronal outgrowth, thus
leading to an increased risk for the development of ASD. The DRGs of eight-day-old
chick embryos were used as my model for analysis. DRGs develop along the spinal cord
in both chicks and humans, as part of the peripheral nervous system, and feature neurons
that extend neurites led by growth cones during their development. The growth cones
eventually establish synaptic connections both with receptors peripherally and also within
the developing spinal cord. Immunostaining and image analysis techniques were used to
evaluate both unexposed (control) DRGs and DRGs exposed to varying concentrations of
VPA. At the time of dissection, the DRGs are lined up along the spinal cord, ready to
innervate target tissues. In culture, they adhere to the treated, charged plastic culture dish
and spread outward. Monoclonal antibody SV2 was used to detect and measure the
extent of differentiating synaptic networks.
Developmental Progression and Staining Specificity
The DRGs attached to the culture dish within a few hours. This was
accompanied by the appearance of early migrating fibroblasts at the peripheral edges.
Following these cells and mainly using them as a migration substrate, neurons with thick
cell bodies (recognizable by their phase halos) and neuronal processes (neurites) began to
extend outward in all directions. Their neuronal processes lengthened, led by growth
cones, and they then began to form synaptic networks. Between 40 and 48 hours of
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culture, the neurites began to assemble into “nerves” that were thicker than neurites, and
consisted of multiple neurites in bundles.
Immunostaining was performed using both primary and secondary antibodies in
order to locate the development of synaptic networks around the explants. Synaptic
networks stained red indicating the presence of neuronal structures having synaptic
vesicles (Figure 3, B and C). This included cell bodies, neurites and growth cones as
well as maturing synapses, as these areas contained differentiating components of
synaptic vesicles (Figure 3, D). In order to exclude non-specific binding of the antibody,
nine explants were taken through all steps of the immunostaining procedure, but were not
exposed to the primary mouse monoclonal SV2 antibody. The secondary anti-mouse
biotinylated antibody binds to the primary, so without it no red color should be observed.
In our case, no red color was observed, indicating little or no non-specific binding of the
antibody (Figure 3, A).
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Figure 3. Composite images of cultured DRG explants after 48 hr. of culture. The
original DRG lies elevated somewhat at the center of a spreading layer of cells.
Elongated neural processes (neurites) are indicated by arrows. A) A no primary antibody
control showing no red stained areas. B) An immunostained control DRG showing its
neuronal network. C) An immunostained DRG exposed to 100µM VPA concentration,
showing a more extensive neuronal network. D) Enlarged area shown inside the box of C
showing matured synapses with clear cell bodies and neurites that had developed during
culture.
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The Effect of Valproic Acid on the Number of Neurites
The DRGs transferred to Primaria culture dishes attached to the dish surface
within the first day of culture and a neuronal network began to grow outward in all
directions from the explant. Explants were removed from culture after 48 hours and
immunostained as described above. Image analysis was performed to examine the
neuronal networks. Noticeable among them were very thin, straight cell processes that
could be traced back to a larger cell body (neuron) and we identified these as neurites
(Figure 3, D). All statistical data accumulated is based on the averages of all neurites
counted for number and measured for length and area for each respective experiment.
The number of DRGs collected and analyzed for neurite number and length was 31
control DRGs, 8 50 µM VPA DRGs, 36 for 100 µM VPA DRGs, 10 for 200 µM VPA
DRGs, and 9 for 300 µM VPA DRGs. The average number of neurites per DRG for each
group is shown in Figure 4. The complete data set is given in Table B1, Appendix B. A
histogram plot of this data showed a normal distribution (Appendix A, A1). Therefore, a
T-TEST was used to determine whether differences were significant. All of the treated
explants, except those treated with 50 µM VPA, showed a significantly larger number of
neurites than controls. However, the treated explants did not differ significantly from one
other. All significance values can be seen in Table C1, Appendix C.

22

Figure 4. Average number of neurites ± standard deviation found in each 12-line random
sample taken from the indicated number of DRG explants. Treatment with VPA resulted
in a greater number of neurites per explant. Error bars show standard deviation.
Asterisks represent significance when compared to the controls with p ≤ 0.05.
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The Effect of Valproic Acid on Neurite Length
As described above, neurites were counted based on whether they touched or
crossed one of the twelve sample lines (Figure 1). Once each such neurite was located,
its length was measured from where it began at the cell body to where it ended at a
corresponding cell body or in the field of view. These were traced using a computer
mouse and length measurements were generated by the Image Pro Premier software in
microns after calibration had been applied. After all analysis was completed, the
measurements generated by the software were each divided in half to make up for the
extra pixels created during tiling. The average length of neurites per DRG was 54 µm for
the control, 71 µm for 50 µM VPA, 112 µm for 100 µM VPA, 74 µm for 200 µM VPA,
and 71 µm for 300 µM VPA. The complete data set is given in Table B2, Appendix B.
A histogram was created for the data set which showed a non-normal distribution (see
Appendix A, A2). This is because the outgrowth of the explants neuronal networks was
radial, therefore there were many more, shorter neurites closer to the edge of the explant.
Thus, lengths tapered oppositely and rapidly with distance from the edge, and these
taperings led to the non-normal distribution (Wiens et al. 2016). Since the data was not
normal, the Wilcoxon Rank Sum Test was used to analyze significance as it accounts for
the non-normally distributed data. The Wilcoxon test showed many significant
differences, most prominently that all treated explants developed neurites that were
significantly greater in length than controls. When compared to each other, neurites from
explants treated with 100 µM VPA were significantly longer than those from explants
treated with 50 µM, 200 µM or 300 µM VPA. Unexpectedly, explants treated with either
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200 µM or 300 µM VPA were not significantly longer than those treated with 50 µM
VPA and there was no significant difference in length between those treated with 200 µM
and 300 µM VPA (see Table C2, Appendix C for all significance values). Figure 5
displays a graphic summary of these results.
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Figure 5. Boxplot of data depicting lengths of neurites collected from a random sample
around explants. Treatment with VPA resulted in neurites with greater lengths when
compared to untreated explants with a maximum effect with 100 µM VPA. A boxplot of
the data is seen here. Boxes represent data measured from 31, 8, 36, 10, and 9 explants
respectively. The heavy black lines represent median lengths, lower end of the boxes
represent first quartiles, upper end of boxes represent third quartiles, and whisker’s show
maxima and minima neurite lengths. Significance analysis showed all lengths being
significantly greater than those of control explants and are represented as p ≤ 0.05 with an
asterisk. The concentration at 100 µM has significance indicated with a double asterisk,
for neurite length at that concentration was significantly greater when compared to
controls and to the other concentrations. See Table C2, Appendix C for all significance
testing.
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The Effect of Valproic Acid on the Area of Synaptogenesis
Area of synaptogenesis around the DRG was also analyzed. It was expected to
increase among those explants treated with VPA. The SV2 antibody used during the
immunostaining procedure specifically binds to synaptic vesicles and their precursor
molecular components assembled in neurons around the DRG. The middle of the explant
was clearly and prominently stained red due to a very high concentration of synaptic
vesicles in that area. However, because of the high density and three-dimensional
arrangement of neurons there, staining was difficult to evaluate accurately. Also, our aim
was to assess the synapses formed during culture, therefore, we restricted analysis to the
circumference of the explant. Before beginning analysis we carefully traced a border
around the body of the explant. The border was drawn around those cells which had not
migrated outward and this could be seen as a noticeable depth change of the cells (Figure
2). Area measurements were then generated in square microns by ImageJ Software with
corrections for pixels and DRG shape accounted for as described in Methods. 10 control
DRGs, 8 50 µM VPA DRGs, 10 100 µM VPA DRGs, 10 200 µM VPA DRGs, and 9 300
µM VPA DRGS were measured for their amount of red-stained synaptogenic area. The
average stained area of explants was 8113 µm2 for the control, 10641 µm2 for 50 µM
VPA, 12119 µm2 for 100 µM VPA, 10040 µm2 for 200 µM VPA, and 13148 µm2 for 300
µM VPA. A complete data set is shown in Table B3, Appendix B. A histogram was
created for the data set and showed non-normal distribution (see Appendix A, A3), so the
Wilcoxon Rank Sum Test was used to test for significance. Explants treated with 300
µM VPA had a significantly larger synaptogenic area than controls. All other
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comparisons were not found to be significantly different (see Table C3, Appendix C for
all significance values). Figure 6 below displays a graphic summary of these results.

Figure 6. Boxplot of the data depicting area of synaptogenesis in square microns of area
around the explants. Treatment with VPA resulted in larger synaptogenic areas around
the explant when compared to untreated DRGs. Boxes represent data measured from 10
controls, 8 50 µM VPA, 10 100 µM VPA, 10 200 µM VPA, and 10 300 µM VPA DRGs.
Treatment with 300 µM VPA resulted in a significantly larger area of synaptogenesis
with p ≤ 0.05 and is shown with an asterisk. Thick black lines represent median, bottom
portion represents first quartile, top portion represents third quartile, and whiskers
represent maxima and minima areas. (See Table C3, Appendix C for all significance
testing values).
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CHAPTER 4
DISCUSSION
Valproic acid is a pharmaceutical primarily used to treat seizures due to its
strong anti-epileptic properties that involve reducing neuronal activity by blocking
sodium and calcium channels and by enhancing the function of GABA, an inhibitory
neurotransmitter. However, maternal ingestion of VPA during pregnancy may have
profound teratogenic effects on the developing fetus which are associated with a 3-fold
increase in the rate of major malformations (Kataoka et al. 2013). Also, VPA ingestion
while pregnant may lead to an increased risk of development of autism-like behaviors in
children. This occurs mainly because of increased histone acetylation leading to hyperconnected neural networks in the brain. In this study, I modeled neurogenesis using DRG
explants from eight day old chick embryos and exposing them to increasing
concentrations of VPA. This allowed for the examination of neurons at the cellular level
including the formation of neurites led by growth cones and neural network formation.
At day six of incubation neurons of DRGs in the chick embryo initiate neurites to
innervate the spinal cord and connect to peripheral receptors. Therefore neurogenesis
begins and accelerates at a time when the same neurogenic events are underway in the
brain and spinal cord. At day eight of incubation, DRGs can be easily dissected from the
spinal cord and cultured.
My results demonstrated that DRGs exposed to VPA initiated more neurites that
were longer when compared to control. This enabled the development of larger neural
networks. These findings strengthen the current hypothesis that VPA exposure leads to
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hyper-excitable neural networks in a developing fetus leading to an “intense world”
characterized by autistic-like behaviors (Markram et al. 2007).
My dose-dependent findings showed a maximum effect on neurite length and
number for those DRGs treated with 100 µM VPA. There are a couple of reasons as to
why this could have happened. There were 36 DRGs that were exposed to 100 µM VPA,
whereas there were only 10 DRGs exposed to 200 µM VPA and 9 DRGs exposed to 300
µM VPA, therefore the data could be slightly off. Another possible reason for this could
be that at exposure to 100 µM VPA activates complete histone deacetylase inhibition and
displays its maximum effect. When the DRGs were exposed to 200 µM and 300 µM the
increase in neurite number and length was still significantly higher than controls, but not
100 µM concentration. This could also be due to VPA inducing a saturable effect, where
increasing concentrations of the chemical do not continue to increase neurite number and
length. The effect for number and length seem to level off at 100 µM, but the area of
synaptogenesis data continues to rise with a maximum and significant effect at 300 µM
VPA. The biological processes measured were different ones therefore it is possible that
neurite number and length have a maximum response at 100 µM, but the synaptogenic
area will continue to increase with increasing concentrations of VPA. In order to resolve
what is happening here, further research should be executed.
The activity of histone deacetylases is an important factor in the regulation of
genes associated with chromatin condensation. It has been shown that HDAC1 is
required to switch neural progenitor cells (NPC) from proliferation to differentiation in
the developing vertebrate retina, and a mutant model of HDAC1 failed to do so therefore
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proliferation of NPCs was increased (Go et al. 2012). By inhibiting the epigenetic
activity of histone deacetylases a group of genes may be turned on that would result in
the increased number of neurites found in this experiment. One such mechanism is the
selective overexpression of the ionotropic NMDA receptor subunits NR2A and NR2B.
Rinaldi and colleagues (2007) performed a study in 2002 that involved prenatally
exposing rats to VPA and monitoring the changes in glutamate mediated synaptic
transmission and plasticity in the neocortex. They found that ionotropic NMDA
receptors are the key receptors underlying synaptic plasticity in the neocortex, so their
data suggests that an important aspect in VPA exposure is related to synaptic plasticity.
These authors also reported that Calcium/Calmodulin-dependent protein kinase II
(CAMKII) is the second messenger most closely linked to ionotropic NMDA receptors,
and was also found to be overexpressed in VPA treated rats. CAMKII mediates synaptic
plasticity, experience-dependent synaptic changes and memory. CAMKII also mediates
the postsynaptic form of long-term potentiation or LTP (an increase in synaptic strength
following stimulation of a chemical synapse) and has also been found to be enhanced in
VPA treated rats. The overexpression of these receptors translates into enhanced NMDA
receptor-mediated synaptic currents and an amplified postsynaptic form of synaptic
plasticity in the neocortex. Their results suggest molecular and synaptic alterations in
children prenatally exposed to VPA (Rinaldi et al. 2007). My findings showed an
increase in average neurite number, length, and in synaptogenic area. This leads us to
believe that HDAC inhibition is a leading mechanism of action in the neural networks of
children exposed to VPA in utero.
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It has also been shown that enhanced activity of the NR2A subunit can lead to
increased brain-derived neurotropic factor (BDNF) expression, which is important in
neuronal development as it has been shown to increase the number of basal dendrites
(Horch and Katz 2002). A study done by Yoo and colleagues (2016) looked at effects of
increased expression of BDNF on neurogenesis in mouse brains. They found increased
neurogenesis and neurite outgrowth during the early developmental stages of mice with
an overexpression of BDNF (Yoo et al. 2002). Our results showing the increased neurite
number, length and area in VPA exposed DRGs are consistent with Yoo's findings,
indicating a possible mechanism by which this is happening. Yoo and colleagues (2002)
also found an increased brain size in mice exhibiting BDNF overexpression, which was
correlated with ASD in its early years of study. In an earlier study published by
Kimpinski and colleagues (1997) a different neurotropin, nerve growth factor (NGF), was
shown to stimulate an increase in the elongation of distal neurites in both neonatal and
adult sensory neurons (Kimpinski et al. 1997). This leads us to believe that HDAC is
switching on groups of neurotropin genes that could lead to longer neurites and a greater
neural area.
Another possible mechanism leading to the increased neural network is VPA’s
ability to regulate the GSK3 pathway. VPA has been shown to prolong NPC
proliferation through phosphorylation of GSK-3β (Go et al. 2012). The GSK3 pathway is
also regulated by BDNF and the NMDA receptor. As described above, exposure to VPA
leads to overexpression of both BDNF and the NMDA receptor (Rinaldi et al. 2007; Yoo
et al. 2002).
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VPA may also regulate Wnt expression by regulating chromatin methylation.
Prenatal exposure to VPA causes demethylation in the promotor regions of Wnt1 and
Wnt2 which increases mRNA and protein levels in the cortical regions of offspring. This
leads to increased levels of β-catenin which, as discussed, can affect the GSK3 pathway
and neurogenesis (Go et al. 2012). The findings of this study support all the mechanisms,
described above, that lead to increased neurogenesis and neurite outgrowth from
exposure to VPA. These findings also support the hypothesis that VPA, as an HDAC
inhibitor, leads to neurons in the cortical areas of the brain to become hyper-excitable.
These findings may also bring into question as to whether other pharmaceuticals that act
as HDAC inhibitors could have the same effects on a developing fetus when exposed in
utero. Overall, our results and those of others align with the theory of an “intense world”
(Markram et al. 2007) in which hyper-functioning microcircuits in the brain regulate
many physical and behavioral characteristic of ASD in children.
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APPENDIX A
HISTOGRAMS

Figure A1. Histogram of neurite number data showing normal distribution
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Figure A2. Histogram of neurite length data showing not normal distribution
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Figure A3. Histogram of synaptogenic area showing data to be not normally distributed
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APPENDIX B
COMPLETE DATA SETS

Table B1. Average, median, minimum, and maximum DRG neurite number. Numbers
listed are a representation of total averages
Average

Median

Minimum

Maximum

Control

16.09667

15

7

29

50 µM

22.75

22.5

10

36

100 µM

25.83333

25

12

42

200 µM

24.9

23.5

13

35

300 µM

22.66667

23

10

30

Table B2. Average, median, minimum, and maximum DRG neurite length. Numbers
listed are a representation of total averages.
Average (µm)

Median (µm)

Minimum (µm)

Control

53.98859

49.747

38.68414

Maximum
(µm)
83.4627

50 µM

70.57807

64.66285

50.23535

102.0684

100 µM

111.802

108.2713

50.33595

193.2348

200 µM

74.08639

71.08172

47.17987

98.751

300 µM

70.75712

66.9584

66.9584

94.73465

.
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Table B3. Average, median, minimum, and maximum DRG synaptogenic area. Numbers
listed are a representative of total averages.

Average (µm)

Median (µm)

Minimum (µm)

Control

8112.56701

5773.16737

622.059195

Maximum
(µm)
26005.6752

50 µM

10641.0942

8651.62218

2723.09832

26768.0041

100 µM

12118.7537

5988.66905

2942.61006

37535.6902

200 µM

10039.9141

7361.0218

2322.1984

22191.9767

300 µM

13148.7849

10713.8654

4867.71738

28075.8222
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APPENDIX C
SIGNIFICANCE TESTING DATA SETS
Table C1. Significance values as determined by the T-TEST for neurite number. Each
treated explant compared to the control and to each other. Bolded values indicate
significance with p ≤ 0.05.

Control

50 µM

100 µM

200 µM

300 µM

0.065764

2.73536^-7

0.002113

0.010594

0.373373

0.567203

0.981834

0.715126

0.205093

50 µM
100 µM
200 µM

0.44674

Table C2. Significance values as determined by the Wilcoxon Rank Sum Test for neurite
length. Each treated explant compared to the control and to each other. Bolded values
indicate significance with p ≤ 0.05.

Control
50 µM
100 µM
200 µM

50 µM

100 µM

200 µM

300 µM

0.005272

8.636 × 10-14

.0005786

0.001416

0.0008243

0.4598

0.9626

0.001064

0.0002873
0.6607
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C3. Significance values as determined by the Wilcoxon Rank Sum Test for synaptogenic
area. Each treated explant compared to the control and to each other. Bolded values
indicate significance with p ≤ 0.05.

Control
50 µM
100 µM
200 µM

50 µM

100 µM

200 µM

300 µM

0.1728

0.2799

0.4262

0.04347

0.8286

0.7168

0.3704

0.8633

0.2775
0.2947

